Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo
2022 · Proceedings of the National Academy of Sciences · 50 citations
https://doi.org/10.1073/pnas.2201073119
J
Jing Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
278
Papers
4.3K
Citations
39
h-index
101
i10-index
Jing Li is an academic researcher from Shenyang Pharmaceutical University. The author has contributed to research in topics: Microbial Natural Products and Biosynthesis & Prostate Cancer Treatment and Research & Fungal Biology and Applications. The author has an h-index of 39, co-authored 237 publications.
ORCID: 0000-0003-2065-9040Papers by this author
worksClinical and genetic risk factors for Fulvestrant treatment in post-menopause ER-positive advanced breast cancer patients
2019 · Journal of Translational Medicine · 29 citations
https://doi.org/10.1186/s12967-018-1734-x
Preparation of poly(lactide-co-glycolide) microspheres and evaluation of pharmacokinetics and tissue distribution of BDMC-PLGA-MS in rats
2017 · Asian Journal of Pharmaceutical Sciences · 25 citations
https://doi.org/10.1016/j.ajps.2017.09.002
The death education needs of patients with advanced cancer: a qualitative research
2024 · BMC Palliative Care · 15 citations
https://doi.org/10.1186/s12904-024-01540-1
The effect of transient receptor potential vanilloid 4 on the intestinal epithelial barrier and human colonic cells was affected by tyrosine-phosphorylated claudin-7
2019 · Biomedicine & Pharmacotherapy · 13 citations
https://doi.org/10.1016/j.biopha.2019.109697
Knockout of cyclin-dependent kinases 8 and 19 leads to depletion of cyclin C and suppresses spermatogenesis and male fertility in mice
2024 · eLife · 7 citations
https://doi.org/10.7554/elife.96465
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat